sl-mercaptoethanol has been researched along with pitavastatin in 1 studies
| Studies (sl-mercaptoethanol) | Trials (sl-mercaptoethanol) | Recent Studies (post-2010) (sl-mercaptoethanol) | Studies (pitavastatin) | Trials (pitavastatin) | Recent Studies (post-2010) (pitavastatin) |
|---|---|---|---|---|---|
| 7 | 0 | 2 | 730 | 192 | 450 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezowski, V; Blanquart, C; Duez, H; Fruchart, JC; Glineur, C; Martin, G; Najib-Fruchart, J; Poulain, P; Staels, B | 1 |
1 other study(ies) available for sl-mercaptoethanol and pitavastatin
| Article | Year |
|---|---|
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Cell Line; Culture Media, Serum-Free; Cyclic N-Oxides; DNA-Binding Proteins; Enzyme Inhibitors; Fenofibrate; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Mercaptoethanol; Phosphorylation; Promoter Regions, Genetic; Pyridines; Quinolines; Rats; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; rho GTP-Binding Proteins; Signal Transduction; Transcription Factors | 2001 |